The aim of this randomized, double-blind clinical trial was to determine the effectiveness of systemic antibiotic application followed by either topical ionized solution (IS) or topical saline solution (placebo) as surgical site infection (SSI) prophylaxis in appendectomy for non-perforated appendicitis. Prophylactic antibiotic was administered pre-incision and either topical IS or placebo was applied presuturing to 529 patients, who were then monitored for 30 days. When topical IS was used, SSI relative risk was 0.739 (95% CI 0.537, 1.019) and the SSI prevention rate was 26.06% (CI -1.8%, 46.3%) . The number needed to treat was 14.80 patients and the number needed to harm was 209 in order for SSI to be avoided. In conclusion, there was a trend for topical IS prophylaxis to reduce SSI frequency in patients undergoing appendectomy for non-perforated appendicitis, but the result was not statistically significant.
Introduction
Antibiotic prophylaxis is the use of antibiotics in infected or potentially infected areas. 1 In elective surgery, single-dose antibiotic prophylaxis is most appropriate in all circumstances unless the intervention is prolonged. Infection is a permanent surgical risk; indeed, there may be an isolated bacterial pathogen in > 90% of surgical wounds at the time of closing. 2 In general, antibiotic treatment used in elective surgery should not exceed 24 -48 h duration and should be applied half an hour before incision, during anaesthetic induction. 3 -6 Appendectomy is a very frequent surgical procedure, with 7 -12% of the population experiencing an appendicular process at some time, and represents two-thirds of laparotomies carried out for acute abdomen. Surgical site infection (SSI) is the most common morbidity following appendectomy. Occurrence varies from 6% to 50%, depending on the antibiotic employed and the characteristics of the appendicitis. 7, 8 In addition to systemic prophylaxis, many surgeons continue to use local antibiotics empirically. Some studies have shown that ionized water (pH 5.0 -7.0, oxidation-reduction potential 600 -800 mV and an approximate concentration of 20 J Tijerina, R Velasco-Rodríguez, C Vásquez et al. Surgical site infection prophylaxis: topical ionized solution vs placebo ppm of chlorine, obtained by combining distilled water and a hypochloric acid solution) has an antimicrobial effect on bacteria, mycobacteria, viruses, fungi and spores. 9 -11 Published data have shown that superoxidized water quickly and effectively (< 2 min) reduces the following pathological micro-organisms (by 5 10 ) in the absence of organic product: Mycobacterium tuberculosis, Mycobacterium chelonae, poliovirus, human immunodeficiency virus, methicillinresistant Staphylococcus aureus, Escherichia coli, Candida albicans, Enterococcus faecalis and Pseudomonas sp. 6,9 -14 The objective of the present study was to determine the effectiveness of systemic antibiotic prophylaxis plus topical prophylaxis with ionized solution (IS) or topical placebo for SSI in appendectomy for non-perforated appendicitis.
Patients and methods

PATIENTS
Patients who were scheduled to undergo open appendectomy for non-perforated appendicitis at the Civil Hospital in Guadalajara, Mexico, between August 2005 and February 2007 were included in this randomized, double-blind, placebocontrolled clinical trial. All patients were monitored for 30 days following operation. For the purposes of analyses, patients were grouped according to their age: 5 -15 years, 16 -45 years, 46 -65 years and > 65 years. Antibiotic prophylaxis was applied preincision and topical IS or placebo was applied pre-suture. The patients were randomly divided into two groups by lottery: the experimental group received systemic prophylactic antibiotic treatment and topical IS; the control group received systemic prophylactic antibiotic treatment and topical saline solution (placebo).
The inclusion criteria selected post-surgical open appendectomy patients presenting with clean-contaminated or with contaminated surgical wounds with a 0 -3 SSI risk classification, who did not require antibiotic treatment for more than 48 h and for whom letters of informed consent had been obtained. Patients who were allergic to the topical solution or who were pregnant were excluded from the study. Elimination criteria included all patients wishing to exit the trial.
The study protocol was approved by the Hospital Ethics Committee of the Guadalajara Civil Hospital, Jalisco, Mexico.
ASEPTIC PROTOCOL
The aseptic protocol that was followed for all patients was: (i) the abdominal area was washed with soap and water; (ii) systemic prophylactic antibiotic was administered according to American Society of Health-System Pharmacists' guidelines 15 and patient medical history 1 h prior to surgical incision; (iii) oxygenation was carried out at 3 l/min for 1 h pre-surgery and for 2 h post-surgery; (iv) a pre-operative scrub was carried out with iodopovidone; (v) dye was removed from the surgical area using alcohol after 5 min; (vi) gloves were washed with sterile solution before surgery; and (vii) surgeon's hands did not leave the surgical area during the procedure.
PREPARATION OF LOCAL PROPHYLACTIC SOLUTION
The head researcher gave a member of the study team (the examiner) the original IS 8 -13 and jars (15 ml). The jars were sterilized according to plasma or gas aseptic filling standards, and the operatives for this procedure wore sterile gloves, face masks and surgical caps and worked in a laminar flow or sterile area. The jars were filled with saline solution or topical IS and labelled for application control, and maintained at a temperature ≤ 25°C in a cool, dark, dry place J Tijerina, R Velasco-Rodríguez, C Vásquez et al.
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in order to retain antimicrobial action. The sterile solutions had a shelf life of 1 month, after which they were discarded if they had not been used. Only the examiner was aware of which solution was contained in each jar.
PROCEDURE FOR APPLYING LOCAL PROPHYLACTIC SOLUTION
Systemic intravenous antibiotic, indicated for appendectomy and in accordance with each patient's medical history, was administered 1 h prior to surgery. The experimental (topical IS) or placebo saline solution was sprayed onto the entire wound area before and after wound closure.
POST-SURGICAL EVALUATION
The head researcher assessed post-surgical wound progression based on the National Nosocomial Infection Surveillance (NNIS) criteria. 16 Sample cultures from wound secretions were taken 48 h after surgery as laboratory support for determining SSI. Data collection was continued over a 30-day postsurgical period.
ASEPTIC TECHNIQUE FOR COLLECTING CULTURE SAMPLES
The surgical area was scrubbed with soap and water, and alcohol was applied and allowed to dry. The wound was squeezed in order to obtain a secretion. The secretion was swabbed and its contents placed in an agar transport medium for post-surgical bacteriological culture.
STATISTICAL ANALYSIS
Data were analysed using GraphPad InStat 3 biostatistics software (GraphPad Software Inc., La Jolla, CA, USA) and Evaluation, Treatment and Diagnosis software, version 1.0.1 (2002), from Ramón y Cajal Hospital, Madrid, Spain. Cumulative and relative frequencies were also obtained. The χ 2 -test, two-tailed unpaired Student's t-test and Mann-Whitney U-test were applied to obtain inferential statistics. Clinical aspects were evaluated by calculation of relative risk (RR), relative risk reduction (RRR), absolute risk reduction (ARR), number needed to treat (NNT) and number needed to harm (NNH). A P-value < 0.05 was considered to be statistically significant.
Results
A total of 529 patients undergoing appendectomy for non-perforated appendicitis were enrolled in the study: 313 (59%) were randomized to the experimental group and 216 (41%) were randomized to the control group. There was a slight predominance of female patients (286 women and 243 men) representing a 1.18:1 ratio. Most cases of appendicitis (326 cases [172 women and 154 men]) occurred in the 16 -45-year range and no statistical differences in terms of gender or age range were observed between the two groups ( Table 1 ). The rate of SSI was 12.0% in the 5 -15-year range, 56.8% in the 16 -45-year range, 24.1% in the 46 -65-year range and 6.8% in > 65-year range.
Appendicitis stage was classified as stage I or stage II, which represented stages of skin closure immediately after surgery (stage I was indicative of better skin healing than stage II). The staging was modified by the addition of zero (0) for surgical cases that turned out not to be appendicitis. Most cases were phase II (427 cases [235 women and 192 men]), although there were no statistically significant between-group differences: 80.7% were stage II, 15.9% were stage I and 3.4% were stage 0.
Of the 313 patients undergoing appendectomy and randomized to receive prophylaxis with IS, 60 presented with SSI, accounting for 19.2% of cases. Similar results were found in the control group in which 56 of J Tijerina, R Velasco-Rodríguez, C Vásquez et al.
Surgical site infection prophylaxis: topical ionized solution vs placebo
the 216 patients presented with infection (25.9%). Overall, SSIs occurred in 58 women and 58 men: 83 infections were superficial, 26 were deep and seven involved the body cavity (organ space); hence SSIs were most frequently superficial (71.6%). There were no statistically significant between-group differences in terms of the rate of SSIs (Table 1 ).
In the topical IS group, 116 (37.1%) cultures were positive and 197 (62.9%) were negative. In the placebo group 104 (48.1) cultures were positive and 112 (51.9%) were negative. It is important to note that the topical IS group had significantly more negative cultures than the placebo group ( Table 2 , P = 0.0142). Of the 309 patients with negative cultures, 20 had an infection. Of these 20, nine had been treated with topical IS at the appendectomy and 11 had been treated with placebo (this difference was not statistically significant). Overall, the most frequent micro-organism identified was Staphylococcus aureus in 23% (51/220) of all culture-positive SSI cases (Fig. 1) . The 
Discussion
To the best of our knowledge, this is the first report on topical prophylaxis with IS in appendectomy patients for non-perforated appendicitis. Clinically, this prophylactic measure appeared to be more effective than topical placebo in preventing SSI but the results failed to reach statistical significance probably due to the small numbers of patients included in the study. There was 26.06% RRR of SSI with topical IS prophylaxis and ARR indicated that, for every 100 patients treated with IS topical prophylaxis, 6.75% would present with SSI. For the NNH, SSI would be reported after 209 applications of IS topical prophylaxis. There were more patients allocated to the IS group relative to the control group (313 versus 216); however, this difference in group numbers occurred entirely by chance.
Surgical site infection presented in 21.9% of patients undergoing open appendectomy for non-perforated appendicitis. This percentage falls mid-way in the internationally acceptable level which was reported as 6 -50% or 5 -34% in two different series. 3, 7 In terms of the NNIS criteria, 16 the most common score was 2, indicating that patients had 6.8 times more probability of nosocomial infection. 3 A Spanish study found that procedure duration was the most influential NNISS factor for infection rate (odds ratio [OR] of 3.43, versus OR 2.60 for contamination degree and OR 2.20 for American Society of Anesthesiologists' physical classification system for patient fitness prior to surgery). 16 In the present study, the most frequent SSI was superficial (71.6% compared with 42.5% in the Spanish study). 16 The micro-organism most frequently reported in conjunction with infected appendectomy sites is S. aureus 1,3,7,17 -20 and, in the present study, S. aureus was the most frequent SSI micro-organism, found in 23% of cases. In the last decade the most significant change has been the emergence of multiresistant bacteria, caused by the therapeutic or prophylactic use of antibiotics that gradually select resistant strains. Enterococcus sp. is reported in the literature as the most frequently isolated microorganism in SSI, followed by E. coli, Candida sp. and, less frequently, Enterobacter sp., Pseudomonas sp., S. aureus, Klebsiella sp. and Streptococcus sp., with other micro-organisms having a lower prevalence. 17, 20, 21 We believe it is important to determine bacterial resistance in each hospital, especially in developing countries where the role of the clinical pharmacist is still in its primary stages. The first step in establishing an organized clinical pharmacy service is to evaluate the current services and determine areas of improvement. 22 In the present study, the most commonly used systemic antibiotic prophylaxis was that recommended in the international guidelines (cefalotin + metronidazole). 15 In a Spanish study, gentamicin + metronidazole was applied as pre-operative systemic prophylaxis resulting in 20% post-appendectomy SSI. 23 Topical IS could be used as an alternative topical prophylaxis, or in conjuction with antibiotics. Additionally, acetic acid at a concentration of 3% has been reported to have an excellent bactericidal effect 24 and may be suitable as a local antiseptic agent, but further clinical studies are necessary.
In conclusion, topical IS as a prophylactic measure to combat post-operative SSI in patients undergoing appendectomy for nonperforated appendicitis appeared to be more effective than topical placebo, but the results failed to reach statistical significance.
